Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege

Yinghua Ma(Cornell University), Timothy Vartanian(Cornell University), Ilana Brito(Cornell University), David Danko(Ekaterinburg State Theatre Institute), Nancy Nealon(Cornell University), Friederike Dündar(Cornell University), Gregory F. Sonnenberg(Cornell University), Jennifer R. Linden(Cornell University), Lily Zexter(Cornell University), Paige Winokur(Hatch (Canada)), Vincent A. Fischetti(Rockefeller University), Michael Mazzucco(Cornell University), Paul Zumbo(Cornell University), Richard Daneman(University of California San Diego), John B. Grigg(Cornell University), Jenny Xiang(Cornell University), Ulrike W. Kaunzner(Cornell University), Evan A. Balmuth(Cornell University), Francisco A. Uzal(California State University, San Bernardino), Kareem Rashid Rumah(Rockefeller University), Susan A. Gauthier(Cornell University), Jai Perumal(Cornell University), Richard A. Rudick(Norwalk Hospital), David R. Sannino(Cornell University), Doron Betel(Cornell University), Daniel Butler(Cornell University), Christopher E. Mason(Cornell University), Bruce A. McClane(University of Pittsburgh), Sylvia Haigh(Cornell University), Zhengming Chen(Cornell University), Baohua Zhao(Hebei Normal University), Kiel M. Telesford(Dartmouth College), Caterina P. Profaci(University of California San Diego)
Journal of Clinical Investigation
February 28, 2023
Cited by 50


Related Papers